During an allogenic bone marrow transplant, healthy bone marrow from a donor is transfused into a patient with a weakened or abnormal immune system. The bone marrow is transfused through a catheter and consists of stem cells that differentiate into mature blood cells to fight disease and infection.
Also Known As:
- Stem cell transplant
- Hematopoietic stem cell transplant
- Bone marrow transplant
- Bone marrow surgery
- Transplant surgery
Conditions Treated with Allogenic Bone Marrow Transplant:
An allogenic bone marrow transplant can be utilized for patients with leukemia, lymphoma, sickle cell anemia, aplastic anemia, multiple myeloma, congenital neutropenia and thalassemia. It is also used when bone marrow has been destroyed by chemotherapy or radiation, or for patients with immunodeficiency syndromes.
There are no comparable non-surgical or surgical alternatives to an allogenic bone marrow transplant.
Anesthesia with Allogenic Bone Marrow Transplant:
Allogenic bone marrow transplant is performed under local anesthesia.
Potential Complications from Allogenic Bone Marrow Transplant:
Possible risks following allogenic bone marrow transplant include infection, bleeding, pain, nausea, headache, chest pain and fever. It is also possible to experience low blood pressure, organ damage and rejection of the transplanted marrow. In children, the procedure can result in a growth delay.
Prognosis after Allogenic Bone Marrow Transplant:
The prognosis for a positive end result following allogenic bone marrow transplant is highly variable.
Recovery from Allogenic Bone Marrow Transplant:
Recovery after allogenic bone marrow transplant can take four to six weeks, or longer.